The Role of Nondigestible Oligosaccharides in Alleviating Human Chronic Diseases by Regulating the Gut Microbiota: A Review

• Published in: Foods 2024-07, Vol.13 (13), p.2157
• Main Authors: Yuan, Meiyu, Zhang, Zhongwei, Liu, Tongying, Feng, Hua, Liu, Yuhuan, Chen, Kai
• Format: Article
• Language: English
• Subjects: ABC transporters; Bacteria; Carbohydrates; Carbon sources; Chronic illnesses; Constipation; Decomposition; Diabetes; Diabetes mellitus; Dietary fiber; Digestive system; E coli; Energy consumption; Energy metabolism; Enzymes; Fatty acids; Fermentation; Gastrointestinal tract; Glucose; gut microbiota; Homeostasis; Immune system; Inflammatory bowel disease; Inflammatory diseases; Intestinal microflora; Liver diseases; Metabolism; Metabolites; Microbiota; Microorganisms; Molecular structure; nondigestible oligosaccharides; obesity; Oligosaccharides; Polymerization; Prebiotics; Probiotics; Reviews; short chain fatty acids; Structure-function relationships; Substrates
• ISSN: 2304-8158; 2304-8158
• DOI: 10.3390/foods13132157

The gut has been a focus of chronic disease research. The gut microbiota produces metabolites that act as signaling molecules and substrates, closely influencing host health. Nondigestible oligosaccharides (NDOs), as a common dietary fiber, play an important role in regulating the structure and function of the gut microbiota. Their mechanism of action is mainly attributed to providing a carbon source as specific probiotics, producing related metabolites, and regulating the gut microbial community. However, due to the selective utilization of oligosaccharides, some factors, such as the type and structure of oligosaccharides, have different impacts on the composition of microbial populations and the production of metabolites in the colon ecosystem. This review systematically describes the key factors influencing the selective utilization of oligosaccharides by microorganisms and elaborates how oligosaccharides affect the host's immune system, inflammation levels, and energy metabolism by regulating microbial diversity and metabolic function, which in turn affects the onset and progress of chronic diseases, especially diabetes, obesity, depression, intestinal inflammatory diseases, and constipation. In this review, we re-examine the interaction mechanisms between the gut microbiota and its associated metabolites and diseases, and we explore new strategies for promoting human health and combating chronic diseases through dietary interventions.